Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS GRANDE PHARMACIE D'AULNAY : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE D'AULNAY is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AULNAY-SOUS-BOIS (93600), this company of category PME shows in 2024 a net income positive of 108 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE D'AULNAY (SIREN 844146993)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C
Net income 108 008 € 95 292 € 170 965 € 290 248 € 204 727 € 215 259 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELAS GRANDE PHARMACIE D'AULNAY generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 215 k€ -> 108 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

108 008 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 127%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

127.182%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.828%

Solvency indicators evolution
SELAS GRANDE PHARMACIE D'AULNAY

Sector positioning

Debt ratio
127.18 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELAS GRANDE PHARMACIE D'... (127.18) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.83% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average

In 2024, the financial autonomy of SELAS GRANDE PHARMACIE D'... (35.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of SELAS GRANDE PHARMACIE D'AULNAY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS GRANDE PHARMACIE D'AULNAY is estimated at 1 507 871 € (range 1 050 057€ - 2 255 862€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1050k€ 1507k€ 2255k€
1 507 871 € Range: 1 050 057€ - 2 255 862€
NAF 5 année 2024

Valuation method used

Net Income Multiple
108 008 € × 14.0x = 1 507 872 €
Range: 1 050 058€ - 2 255 862€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE D'AULNAY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE D'AULNAY

What is the revenue of SELAS GRANDE PHARMACIE D'AULNAY ?

The revenue of SELAS GRANDE PHARMACIE D'AULNAY is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS GRANDE PHARMACIE D'AULNAY profitable?

Yes, SELAS GRANDE PHARMACIE D'AULNAY generated a net profit of 108 k€ in 2024.

Where is the headquarters of SELAS GRANDE PHARMACIE D'AULNAY ?

The headquarters of SELAS GRANDE PHARMACIE D'AULNAY is located in AULNAY-SOUS-BOIS (93600), in the department Seine-Saint-Denis.

Where to find the tax return of SELAS GRANDE PHARMACIE D'AULNAY ?

The tax return of SELAS GRANDE PHARMACIE D'AULNAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE D'AULNAY operate?

SELAS GRANDE PHARMACIE D'AULNAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.